 |
Prescription and Over-the-Counter Drug Product List
23rd Edition
Cumulative Supplement Number 11: November 2004
NOTE: The format for the Monthly Additions/Deletions Drug
Product List has changed as of the July Cumulative Supplement (CS) of the 21st
Edition to mirror the CS. Refer to the CS Preface section 1.5
CUMULATIVE SUPPLEMENT LEGEND.
ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE
TABLET; ORAL
PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN
>A> AB ANDRX PHARMS 650MG;100MG N76609 001 Nov 16, 2004 Nov NEWA
ALBUTEROL SULFATE
AEROSOL, METERED; INHALATION
>D> ALBUTEROL SULFATE
>D> BX + IVAX RES EQ 0.09MG BASE/INH N21457 001 Oct 29, 2004 Nov CTNA
>A> ALBUTEROL SULFATE HFA
>A> BX + IVAX RES EQ 0.09MG BASE/INH N21457 001 Oct 29, 2004 Nov CTNA
TABLET, EXTENDED RELEASE; ORAL
ALBUTEROL SULFATE
>D> + PLIVA EQ 4MG BASE N76130 002 Sep 26, 2002 Nov CRLD
>A> EQ 4MG BASE N76130 002 Sep 26, 2002 Nov CRLD
ALPROSTADIL
INJECTABLE; INJECTION
CAVERJECT
>A> @ PFIZER 0.005MG/ML N20755 001 Oct 31, 1997 Nov CAHN
>A> @ 0.01MG/ML N20755 002 Oct 01, 1997 Nov CAHN
>A> @ 0.02MG/ML N20755 003 Oct 01, 1997 Nov CAHN
>D> @ PHARMACIA AND 0.005MG/ML N20755 001 Oct 31, 1997 Nov CAHN
>D> @ 0.01MG/ML N20755 002 Oct 01, 1997 Nov CAHN
>D> @ 0.02MG/ML N20755 003 Oct 01, 1997 Nov CAHN
BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
GEL; TOPICAL
BENZACLIN
>D> + DERMIK LABS 5%;EQ 1% BASE N50756 001 Dec 21, 2000 Nov CTEC
>A> BT + 5%;EQ 1% BASE N50756 001 Dec 21, 2000 Nov CTEC
DUAC
>D> + STIEFEL 5%;EQ 1% BASE N50741 001 Aug 26, 2002 Nov CTEC
>A> BT + 5%;EQ 1% BASE N50741 001 Aug 26, 2002 Nov CTEC
BETAMETHASONE VALERATE
>A> AEROSOL, FOAM; TOPICAL
>A> LUXIQ
>A> + CONNETICS EQ 0.12% BASE N20934 001 Feb 28, 1999 Nov CDFR
>D> AEROSOL; TOPICAL
>D> LUXIQ
>D> + CONNETICS EQ 0.12% BASE N20934 001 Feb 28, 1999 Nov CDFR
CAFFEINE; ERGOTAMINE TARTRATE
TABLET; ORAL
>A> CAFERGOT
>A> AA + SANDOZ 100MG;1MG N84294 001 Nov CTNA
>D> AA + ERSANDOZ 100MG;1MG N84294 001 Nov CTNA
CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
INJECTABLE; INJECTION
DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER
>D> AP B BRAUN 33MG/100ML;5GM/100ML;30MG/100ML;8 N18256 001 Nov DISC
60MG/100ML
>A> @ 33MG/100ML;5GM/100ML;30MG/100ML;8 N18256 001 Nov DISC
60MG/100ML
CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
INJECTABLE; INJECTION
RINGER'S IN PLASTIC CONTAINER
>D> AP B BRAUN 33MG/100ML;30MG/100ML;860MG/100M N18721 001 Nov 09, 1982 Nov DISC
>A> @ 33MG/100ML;30MG/100ML;860MG/100M N18721 001 Nov 09, 1982 Nov DISC
CARBOPLATIN
INJECTABLE; INJECTION
CARBOPLATIN
>A> AP PLIVA 50MG/VIAL N76602 001 Nov 16, 2004 Nov NEWA
>A> AP 150MG/VIAL N76602 002 Nov 16, 2004 Nov NEWA
>A> AP 450MG/VIAL N76602 003 Nov 16, 2004 Nov NEWA
INJECTABLE; IV (INFUSION)
>A> CARBOPLATIN
>A> AP MAYNE PHARMA USA 600MG/60ML (10MG/ML) N77059 001 Nov 23, 2004 Nov NEWA
PARAPLATIN
>D> + BRISTOL MYERS EQ 600MG /60ML(10MG/ML) N20452 004 Jan 15, 2004 Nov CFTG
>A> AP + EQ 600MG /60ML(10MG/ML) N20452 004 Jan 15, 2004 Nov CFTG
CEFAZOLIN SODIUM
INJECTABLE; INJECTION
CEFAZOLIN SODIUM
>D> AP + AM PHARM PARTNERS EQ 500MG BASE/VIAL N64169 001 Aug 14, 1998 Nov CRLD
>A> AP EQ 500MG BASE/VIAL N64169 001 Aug 14, 1998 Nov CRLD
>D> AP EQ 20GM BASE/VIAL N64170 002 Mar 18, 1998 Nov CRLD
>A> AP + EQ 20GM BASE/VIAL N64170 002 Mar 18, 1998 Nov CRLD
CEPHALEXIN
TABLET; ORAL
CEPHALEXIN
>D> AB TEVA EQ 250MG BASE N63023 001 Jan 12, 1989 Nov CTEC
>A> EQ 250MG BASE N63023 001 Jan 12, 1989 Nov CTEC
CILOSTAZOL
TABLET; ORAL
>A> CILOSTAZOL
>A> AB ALPHAPHARM 50MG N77019 001 Nov 23, 2004 Nov NEWA
>A> AB 100MG N77019 002 Nov 23, 2004 Nov NEWA
>A> AB AMIDE PHARM 100MG N77028 002 Nov 26, 2004 Nov NEWA
>A> AB COREPHARMA 100MG N77022 001 Nov 23, 2004 Nov NEWA
>A> AB EON 100MG N77021 001 Nov 23, 2004 Nov NEWA
>A> AB TEVA 50MG N77027 001 Nov 24, 2004 Nov NEWA
>A> AB 100MG N77027 002 Nov 24, 2004 Nov NEWA
PLETAL
>D> + OTSUKA 50MG N20863 001 Jan 15, 1999 Nov CFTG
>A> AB + 50MG N20863 001 Jan 15, 1999 Nov CFTG
>D> + 100MG N20863 002 Jan 15, 1999 Nov CFTG
>A> AB + 100MG N20863 002 Jan 15, 1999 Nov CFTG
CIPROFLOXACIN HYDROCHLORIDE
TABLET; ORAL
CIPROFLOXACIN
>A> AB TORPHARM EQ 250MG BASE N76896 001 Nov 04, 2004 Nov NEWA
>A> AB EQ 500MG BASE N76896 002 Nov 04, 2004 Nov NEWA
>A> AB EQ 750MG BASE N76896 003 Nov 04, 2004 Nov NEWA
CITALOPRAM HYDROBROMIDE
TABLET; ORAL
CITALOPRAM HYDROBROMIDE
>A> AB ALPHAPHARM EQ 10MG BASE N77037 001 Nov 05, 2004 Nov NEWA
>A> AB EQ 20MG BASE N77037 002 Nov 05, 2004 Nov NEWA
>A> AB EQ 40MG BASE N77037 003 Nov 05, 2004 Nov NEWA
>A> AB APOTEX EQ 10MG BASE N77046 001 Nov 24, 2004 Nov NEWA
>A> AB EQ 20MG BASE N77046 002 Nov 24, 2004 Nov NEWA
>A> AB EQ 40MG BASE N77046 003 Nov 24, 2004 Nov NEWA
>A> AB CARACO EQ 10MG BASE N77032 001 Nov 12, 2004 Nov NEWA
>A> AB EQ 20MG BASE N77032 002 Nov 12, 2004 Nov NEWA
>A> AB EQ 40MG BASE N77032 003 Nov 12, 2004 Nov NEWA
>A> AB IVAX PHARMS EQ 10MG BASE N77048 001 Nov 16, 2004 Nov NEWA
>A> AB EQ 20MG BASE N77048 002 Nov 16, 2004 Nov NEWA
>A> AB EQ 40MG BASE N77048 003 Nov 16, 2004 Nov NEWA
>A> AB KALI LABS EQ 10MG BASE N77042 001 Nov 05, 2004 Nov NEWA
>A> AB EQ 20MG BASE N77042 002 Nov 05, 2004 Nov NEWA
>A> AB EQ 40MG BASE N77042 003 Nov 05, 2004 Nov NEWA
>A> AB ROXANE EQ 10MG BASE N77041 001 Nov 23, 2004 Nov NEWA
>A> AB EQ 20MG BASE N77041 002 Nov 23, 2004 Nov NEWA
>A> AB EQ 40MG BASE N77041 003 Nov 23, 2004 Nov NEWA
>A> AB WATSON LABS EQ 10MG BASE N77044 001 Nov 05, 2004 Nov NEWA
>A> AB EQ 20MG BASE N77044 002 Nov 05, 2004 Nov NEWA
>A> AB EQ 40MG BASE N77044 003 Nov 05, 2004 Nov NEWA
CLINDAMYCIN PHOSPHATE
>A> AEROSOL, FOAM; TOPICAL
>A> EVOCLIN
>A> + CONNETICS 1% N50801 001 Oct 22, 2004 Nov CDFR
>D> AEROSOL; TOPICAL
>D> EVOCLIN FOAM
>D> + CONNETICS 1% N50801 001 Oct 22, 2004 Nov CDFR
CREAM; VAGINAL
>A> CLINDESSE
>A> KV PHARM EQ 2% BASE N50793 001 Nov 30, 2004 Nov NEWA
CLOBETASOL PROPIONATE
>A> AEROSOL, FOAM; TOPICAL
>A> OLUX
>A> + CONNETICS 0.05% N21142 001 May 26, 2000 Nov CDFR
>D> AEROSOL; TOPICAL
>D> OLUX FOAM
>D> + CONNETICS 0.05% N21142 001 May 26, 2000 Nov CDFR
DEXTROSE
INJECTABLE; INJECTION
DEXTROSE 10% IN PLASTIC CONTAINER
>D> AP B BRAUN 10GM/100ML N18046 001 Nov DISC
>A> @ 10GM/100ML N18046 001 Nov DISC
DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM
INJECTABLE; INJECTION
ISOLYTE S IN DEXTROSE 5% IN PLASTIC CONTAINER
>D> AP B BRAUN 5GM/100ML;30MG/100ML;37MG/100ML;3 N19843 001 Aug 09, 1993 Nov CTEC
70MG/100ML;530MG/100ML;500MG/100
>A> 5GM/100ML;30MG/100ML;37MG/100ML;3 N19843 001 Aug 09, 1993 Nov CTEC
70MG/100ML;530MG/100ML;500MG/100
>D> ISOLYTE S W/ DEXTROSE 5% IN PLASTIC CONTAINER
>D> AP B BRAUN 5GM/100ML;30MG/100ML;37MG/100ML;3 N18274 001 Nov DISC
70MG/100ML;530MG/100ML;500MG/100
>A> @ 5GM/100ML;30MG/100ML;37MG/100ML;3 N18274 001 Nov DISC
70MG/100ML;530MG/100ML;500MG/100
PLASMA-LYTE 148 AND DEXTROSE 5% IN PLASTIC CONTAINER
>D> AP BAXTER HLTHCARE 5GM/100ML;30MG/100ML;37MG/100ML;3 N17451 001 Nov CTEC
68MG/100ML;526MG/100ML;502MG/100
>A> 5GM/100ML;30MG/100ML;37MG/100ML;3 N17451 001 Nov CTEC
68MG/100ML;526MG/100ML;502MG/100
DILTIAZEM HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL
CARDIZEM SR
>D> @ AVENTIS PHARMS 60MG N19471 001 Jan 23, 1989 Nov CAHN
>D> @ 90MG N19471 002 Jan 23, 1989 Nov CAHN
>D> @ 120MG N19471 003 Jan 23, 1989 Nov CAHN
>D> @ 180MG N19471 004 Jan 23, 1989 Nov CAHN
>A> @ BIOVAIL 60MG N19471 001 Jan 23, 1989 Nov CAHN
>A> @ 90MG N19471 002 Jan 23, 1989 Nov CAHN
>A> @ 120MG N19471 003 Jan 23, 1989 Nov CAHN
>A> @ 180MG N19471 004 Jan 23, 1989 Nov CAHN
INJECTABLE; INJECTION
CARDIZEM
>D> AP + AVENTIS PHARMS 100MG/VIAL N20792 001 Sep 05, 1997 Nov CAHN
>A> AP + BIOVAIL 100MG/VIAL N20792 001 Sep 05, 1997 Nov CAHN
TABLET; ORAL
CARDIZEM
>D> AB AVENTIS PHARMS 30MG N18602 001 Nov 05, 1982 Nov CAHN
>D> AB 60MG N18602 002 Nov 05, 1982 Nov CAHN
>D> AB 90MG N18602 003 Dec 08, 1986 Nov CAHN
>D> AB + 120MG N18602 004 Dec 08, 1986 Nov CAHN
>A> AB BIOVAIL 30MG N18602 001 Nov 05, 1982 Nov CAHN
>A> AB BIOVAIL 60MG N18602 002 Nov 05, 1982 Nov CAHN
>A> AB 90MG N18602 003 Dec 08, 1986 Nov CAHN
>A> AB + 120MG N18602 004 Dec 08, 1986 Nov CAHN
DOXEPIN HYDROCHLORIDE
CREAM; TOPICAL
ZONALON
>D> + BIOGLAN PHARMS 5% N20126 001 Apr 01, 1994 Nov CAHN
>A> + BRADLEY PHARMS 5% N20126 001 Apr 01, 1994 Nov CAHN
EPLERENONE
TABLET; ORAL
INSPRA
>D> GD SEARLE LLC 50MG N21437 002 Sep 27, 2002 Nov CRLD
>A> + 50MG N21437 002 Sep 27, 2002 Nov CRLD
>D> + 100MG N21437 003 Sep 27, 2002 Nov DISC
>A> @ 100MG N21437 003 Sep 27, 2002 Nov DISC
>A> ERLOTINIB HYDROCHLORIDE
>A> TABLET; ORAL
>A> TARCEVA
>A> OSI PHARMS EQ 25MG BASE N21743 001 Nov 18, 2004 Nov NEWA
>A> EQ 100MG BASE N21743 002 Nov 18, 2004 Nov NEWA
>A> + EQ 150MG BASE N21743 003 Nov 18, 2004 Nov NEWA
ESTRADIOL; NORGESTIMATE
TABLET; ORAL
PREFEST
>A> + DURAMED 1MG,1MG;0.09MG N21040 001 Oct 22, 1999 Nov CAHN
>D> + KING PHARMS 1MG,1MG;0.09MG N21040 001 Oct 22, 1999 Nov CAHN
ETHINYL ESTRADIOL; LEVONORGESTREL
TABLET; ORAL-21
>D> TRIPHASIL-21
>D> AB + WYETH PHARMS INC 0.03MG,0.04MG,0.03MG;0.05MG,0.075M N19192 001 Nov 01, 1984 Nov DISC
G,0.125MG
>A> @ 0.03MG,0.04MG,0.03MG;0.05MG,0.075M N19192 001 Nov 01, 1984 Nov DISC
G,0.125MG
TABLET; ORAL-28
LEVONORGESTREL AND ETHINYL ESTRADIOL
>A> AB1 WATSON LABS 0.02MG;0.1MG N76625 001 Nov 18, 2004 Nov NEWA
TRIPHASIL-28
>D> @ WYETH PHARMS INC 0.03MG,0.04MG,0.03MG;0.05MG,0.075M N19190 001 Nov 01, 1984 Nov CMFD
G,0.125MG
>A> AB + 0.03MG,0.04MG,0.03MG;0.05MG,0.075M N19190 001 Nov 01, 1984 Nov CMFD
G,0.125MG
ETHINYL ESTRADIOL; NORETHINDRONE
TABLET; ORAL-21
>D> NORCEPT-E 1/35 21
>D> AB GYNOPHARMA 0.035MG;1MG N71545 001 Feb 09, 1989 Nov DISC
>A> @ ORTHO MCNEIL 0.035MG;1MG N71545 001 Feb 09, 1989 Nov DISC
TABLET; ORAL-28
>D> NORCEPT-E 1/35 28
>D> AB GYNOPHARMA 0.035MG;1MG N71546 001 Feb 09, 1989 Nov DISC
>A> @ ORTHO MCNEIL 0.035MG;1MG N71546 001 Feb 09, 1989 Nov DISC
>A> ORTHO-NOVUM 10/11-28
>A> AB ORTHO MCNEIL 0.035MG,0.035MG;0.5MG,1MG N18354 002 Jan 11, 1982 Nov CTNA
>D> ORTHO-NOVUM 10/11-28 IN PLASTIC CONTAINER
>D> AB ORTHO MCNEIL 0.035MG,0.035MG;0.5MG,1MG N18354 002 Jan 11, 1982 Nov CTNA
FELODIPINE
TABLET, EXTENDED RELEASE; ORAL
>A> FELODIPINE
>A> AB MUTUAL PHARM 2.5MG N75896 001 Nov 02, 2004 Nov NEWA
>A> AB 5MG N75896 002 Nov 02, 2004 Nov NEWA
>A> AB 10MG N75896 003 Nov 02, 2004 Nov NEWA
PLENDIL
>D> ASTRAZENECA 2.5MG N19834 004 Sep 22, 1994 Nov CFTG
>A> AB 2.5MG N19834 004 Sep 22, 1994 Nov CFTG
>D> 5MG N19834 001 Jul 25, 1991 Nov CFTG
>A> AB ASTRAZENECA 5MG N19834 001 Jul 25, 1991 Nov CFTG
>D> + 10MG N19834 002 Jul 25, 1991 Nov CFTG
>A> AB + 10MG N19834 002 Jul 25, 1991 Nov CFTG
FENOFIBRATE
CAPSULE; ORAL
>A> ANTARA (MICRONIZED)
>A> RELIANT PHARMS 43MG N21695 001 Nov 30, 2004 Nov NEWA
>A> 87MG N21695 002 Nov 30, 2004 Nov NEWA
>A> + 130MG N21695 003 Nov 30, 2004 Nov NEWA
TABLET; ORAL
>A> TRICOR
>A> ABBOTT 48MG N21656 001 Nov 05, 2004 Nov NEWA
>A> + 145MG N21656 002 Nov 05, 2004 Nov NEWA
FLUCYTOSINE
CAPSULE; ORAL
ANCOBON
>A> ICN 250MG N17001 001 Nov CAHN
>A> + 500MG N17001 002 Nov CAHN
>D> VALEANT PHARM 250MG N17001 001 Nov CAHN
>D> + 500MG N17001 002 Nov CAHN
FOSINOPRIL SODIUM; HYDROCHLOROTHIAZIDE
TABLET; ORAL
>A> FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
>A> AB ANDRX PHARMS 10MG;12.5MG N76608 001 Dec 03, 2004 Nov NEWA
>A> AB 20MG;12.5MG N76608 002 Dec 03, 2004 Nov NEWA
MONOPRIL-HCT
>D> BRISTOL MYERS 10MG;12.5MG N20286 002 Nov 30, 1994 Nov CFTG
>A> AB 10MG;12.5MG N20286 002 Nov 30, 1994 Nov CFTG
>D> + 20MG;12.5MG N20286 001 Nov 30, 1994 Nov CFTG
>A> AB + 20MG;12.5MG N20286 001 Nov 30, 1994 Nov CFTG
>A> GADOBENATE DIMEGLUMINE
>A> INJECTABLE; INTRAVENOUS
>A> MULTIHANCE
>A> + BRACCO 2.645GM/5ML (529MG/ML) N21357 001 Nov 23, 2004 Nov NEWA
>A> + 5.29GM/10ML (529MG/ML) N21357 002 Nov 23, 2004 Nov NEWA
>A> + 7.935GM/15ML (529MG/ML) N21357 003 Nov 23, 2004 Nov NEWA
>A> + 10.58GM/20ML (529MG/ML) N21357 004 Nov 23, 2004 Nov NEWA
>A> MULTIHANCE MULTIPACK
>A> + BRACCO 26.45GM/50ML (529MG/ML) N21358 001 Nov 23, 2004 Nov NEWA
>A> + 52.9GM/100ML (529MG/ML) N21358 002 Nov 23, 2004 Nov NEWA
GLYBURIDE; METFORMIN HYDROCHLORIDE
TABLET; ORAL
GLYBURIDE AND METFORMIN HCL
>A> AB COREPHARMA 1.25MG;250MG N76731 001 Nov 19, 2004 Nov NEWA
>A> AB 2.5MG;500MG N76731 002 Nov 19, 2004 Nov NEWA
>A> AB 5MG;500MG N76731 003 Nov 19, 2004 Nov NEWA
HALOPERIDOL LACTATE
CONCENTRATE; ORAL
HALOPERIDOL
>D> AA COPLEY PHARM EQ 2MG BASE/ML N71617 001 Dec 01, 1988 Nov CRLD
>A> AA + EQ 2MG BASE/ML N71617 001 Dec 01, 1988 Nov CRLD
>D> AA + TEVA EQ 2MG BASE/ML N71015 001 Aug 25, 1987 Nov DISC
>A> @ EQ 2MG BASE/ML N71015 001 Aug 25, 1987 Nov DISC
HYDROCORTISONE
CREAM; TOPICAL
ANUSOL HC
>D> AT PARKEDALE 2.5% N88250 001 Jun 06, 1984 Nov CAHN
>A> AT SALIX PHARMS 2.5% N88250 001 Jun 06, 1984 Nov CAHN
>A> IBUPROFEN; OXYCODONE HYDROCHLORIDE
>A> TABLET; ORAL
>A> COMBUNOX
>A> + FOREST LABS 450MG;5MG N21378 001 Nov 26, 2004 Nov NEWA
INDIUM IN 111 CHLORIDE
INJECTABLE; INJECTION
INDICLOR
>A> + AMERSHAM 2mCi/0.2ML N19862 001 Dec 29, 1992 Nov CMS1
INDIUM IN 111 CHLORIDE
>A> + MALLINCKRODT 5mCi/0.5ML N19841 001 Sep 27, 1994 Nov CMS1
IPRATROPIUM BROMIDE
AEROSOL, METERED; INHALATION
>A> ATROVENT HFA
>A> + BOEHRINGER 0.021MG/INH N21527 001 Nov 27, 2004 Nov NEWA
LEVOTHYROXINE SODIUM
TABLET; ORAL
THYRO-TABS
>A> BX LLOYD 0.137MG N21116 012 Dec 07, 2004 Nov NEWA
UNITHROID
>D> AB1, STEVENS J 0.025MG N21210 001 Aug 21, 2000 Nov CTEC
AB3
>A> AB1, 0.025MG N21210 001 Aug 21, 2000 Nov CTEC
AB2,
AB3
>D> AB1, 0.05MG N21210 002 Aug 21, 2000 Nov CTEC
AB3
>A> AB1, 0.05MG N21210 002 Aug 21, 2000 Nov CTEC
AB2,
AB3
>D> AB1, 0.075MG N21210 003 Aug 21, 2000 Nov CTEC
AB3
>A> AB1, 0.075MG N21210 003 Aug 21, 2000 Nov CTEC
AB2,
AB3
>D> AB1, 0.088MG N21210 004 Aug 21, 2000 Nov CTEC
AB3
>A> AB1, 0.088MG N21210 004 Aug 21, 2000 Nov CTEC
AB2,
AB3
>D> AB1, 0.1MG N21210 005 Aug 21, 2000 Nov CTEC
AB3
>A> AB1, 0.1MG N21210 005 Aug 21, 2000 Nov CTEC
AB2,
AB3
>D> AB1, 0.112MG N21210 006 Aug 21, 2000 Nov CTEC
AB3
>A> AB1, 0.112MG N21210 006 Aug 21, 2000 Nov CTEC
AB2,
AB3
>D> AB1, 0.125MG N21210 007 Aug 21, 2000 Nov CTEC
AB3
>A> AB1, 0.125MG N21210 007 Aug 21, 2000 Nov CTEC
AB2,
AB3
>D> AB1, 0.15MG N21210 008 Aug 21, 2000 Nov CTEC
AB3
>A> AB1, 0.15MG N21210 008 Aug 21, 2000 Nov CTEC
AB2,
AB3
>D> AB1, 0.175MG N21210 009 Aug 21, 2000 Nov CTEC
AB3
>A> AB1, 0.175MG N21210 009 Aug 21, 2000 Nov CTEC
AB2,
AB3
>D> AB1, 0.2MG N21210 010 Aug 21, 2000 Nov CTEC
AB3
>A> AB1, 0.2MG N21210 010 Aug 21, 2000 Nov CTEC
AB2,
AB3
>D> AB1,+ 0.3MG N21210 011 Aug 21, 2000 Nov CTEC
AB3
>A> AB1,+ 0.3MG N21210 011 Aug 21, 2000 Nov CTEC
AB2,
AB3
LIDOCAINE; PRILOCAINE
>D> DISC; TOPICAL
>D> EMLA
>D> + ASTRAZENECA 2.5%;2.5% N20962 001 Feb 04, 1998 Nov DISC
>A> @ 2.5%;2.5% N20962 001 Feb 04, 1998 Nov DISC
LITHIUM CARBONATE
CAPSULE; ORAL
LITHIUM CARBONATE
>A> AB APOTEX 300MG N76795 001 Nov 22, 2004 Nov NEWA
LORAZEPAM
INJECTABLE; INJECTION
LORAZEPAM
>A> AP INTL MEDICATION SYS 2MG/ML N76150 001 Nov 15, 2004 Nov NEWA
TABLET; ORAL
LORAZEPAM
>D> AB WATSON LABS 1MG N71087 001 Mar 23, 1987 Nov DISC
>A> @ 1MG N71087 001 Mar 23, 1987 Nov DISC
>D> AB 2MG N71088 001 Mar 23, 1987 Nov DISC
>A> @ 2MG N71088 001 Mar 23, 1987 Nov DISC
LOXAPINE SUCCINATE
CAPSULE; ORAL
LOXAPINE
>A> AB MYLAN EQ 5MG BASE N76762 001 Nov 01, 2004 Nov NEWA
>A> AB EQ 10MG BASE N76762 002 Nov 01, 2004 Nov NEWA
>A> AB EQ 25MG BASE N76762 003 Nov 01, 2004 Nov NEWA
>A> AB EQ 50MG BASE N76762 004 Nov 01, 2004 Nov NEWA
MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM
INJECTABLE; INJECTION
ISOLYTE S IN PLASTIC CONTAINER
>D> AP B BRAUN 30MG/100ML;37MG/100ML;370MG/100M N18252 001 Nov DISC
L;530MG/100ML;500MG/100ML
>A> @ 30MG/100ML;37MG/100ML;370MG/100M N18252 001 Nov DISC
L;530MG/100ML;500MG/100ML
MEGESTROL ACETATE
SUSPENSION; ORAL
MEGESTROL ACETATE
>A> AB MORTON GROVE 40MG/ML N76721 001 Nov 01, 2004 Nov NEWA
MESALAMINE
SUPPOSITORY; RECTAL
CANASA
>D> + AXCAN SCANDIPHARM 500MG N21252 001 Jan 05, 2001 Nov CRLD
>A> 500MG N21252 001 Jan 05, 2001 Nov CRLD
>A> + 1GM N21252 002 Nov 05, 2004 Nov NEWA
MIDODRINE HYDROCHLORIDE
TABLET; ORAL
MIDODRINE HCL
>A> AB UPSHER SMITH 2.5MG N76725 001 Nov 03, 2004 Nov NEWA
>A> AB 5MG N76725 002 Nov 03, 2004 Nov NEWA
>A> AB 10MG N76725 003 Nov 03, 2004 Nov NEWA
NALTREXONE HYDROCHLORIDE
TABLET; ORAL
REVIA
>D> AB + BARR PHARMS 50MG N18932 001 Nov 20, 1984 Nov CAHN
>A> AB + DURAMED 50MG N18932 001 Nov 20, 1984 Nov CAHN
OFLOXACIN
>A> SOLUTION/DROPS; OPHTHALMIC
>A> OFLOXACIN
>A> AT PHARMAFORCE 0.3% N76830 001 Aug 31, 2004 Nov CDFR
>D> SOLUTION; OPHTHALMIC
>D> OFLOXACIN
>D> AT PHARMAFORCE EQ 0.3% BASE N76830 001 Aug 31, 2004 Nov CDFR
>A> OMEGA-3-ACID ETHYL ESTERS
>A> CAPSULE; ORAL
>A> OMACOR
>A> + ROSS PRODS 1GM N21654 001 Nov 10, 2004 Nov NEWA
OXAZEPAM
CAPSULE; ORAL
SERAX
>D> @ ALPHARMA US 15MG N15539 004 Nov CMFD
>A> AB 15MG N15539 004 Nov CMFD
>D> TABLET; ORAL
>D> SERAX
>D> + ALPHARMA US 15MG N15539 008 Nov DISC
>A> @ 15MG N15539 008 Nov DISC
OXYTOCIN
INJECTABLE; INJECTION
OXYTOCIN
>D> AP AM PHARM PARTNERS 10USP UNITS/ML N18248 001 Nov CRLD
>A> AP + 10USP UNITS/ML N18248 001 Nov CRLD
PACLITAXEL
INJECTABLE; INJECTION
PACLITAXEL
>A> AP SUPERGEN 6MG/ML N75436 001 Nov 12, 2004 Nov NEWA
PAROXETINE MESYLATE
TABLET; ORAL
>D> PAROXETINE MESYLATE
>D> SYNTHON PHARMS EQ 10MG BASE N21299 001 Jul 03, 2003 Nov CTNA
>D> EQ 20MG BASE N21299 002 Jul 03, 2003 Nov CTNA
>D> EQ 30MG BASE N21299 003 Jul 03, 2003 Nov CTNA
>D> + EQ 40MG BASE N21299 004 Jul 03, 2003 Nov CTNA
>A> PEXEVA
>A> SYNTHON PHARMS EQ 10MG BASE N21299 001 Jul 03, 2003 Nov CTNA
>A> EQ 20MG BASE N21299 002 Jul 03, 2003 Nov CTNA
>A> EQ 30MG BASE N21299 003 Jul 03, 2003 Nov CTNA
>A> + EQ 40MG BASE N21299 004 Jul 03, 2003 Nov CTNA
PENICILLIN G PROCAINE
INJECTABLE; INJECTION
>A> PENICILLIN G PROCAINE
>A> + KING PHARMS 300,000 UNITS/ML N60101 002 Nov CTNA
>A> + 600,000 UNITS/ML N60101 001 Nov CTNA
>D> WYCILLIN
>D> + KING PHARMS 300,000 UNITS/ML N60101 002 Nov CTNA
>D> + 600,000 UNITS/ML N60101 001 Nov CTNA
PERINDOPRIL ERBUMINE
TABLET; ORAL
ACEON
>D> SOLVAY PHARMA 2MG N20184 001 Dec 30, 1993 Nov CAHN
>D> 4MG N20184 002 Dec 30, 1993 Nov CAHN
>D> + 8MG N20184 003 Dec 30, 1993 Nov CAHN
>A> SOLVAY PHARMS 2MG N20184 001 Dec 30, 1993 Nov CAHN
>A> 4MG N20184 002 Dec 30, 1993 Nov CAHN
>A> + 8MG N20184 003 Dec 30, 1993 Nov CAHN
PILOCARPINE HYDROCHLORIDE
TABLET; ORAL
>A> PILOCARPINE HCL
>A> AB COREPHARMA 5MG N76746 001 Nov 16, 2004 Nov NEWA
SALAGEN
>D> MGI PHARMA INC 5MG N20237 001 Mar 22, 1994 Nov CFTG
>A> AB 5MG N20237 001 Mar 22, 1994 Nov CFTG
POTASSIUM CHLORIDE
TABLET, EXTENDED RELEASE; ORAL
KAON CL-10
>D> @ SAVAGE LABS 10MEQ N17046 002 Nov CMFD
>A> BC 10MEQ N17046 002 Nov CMFD
RANITIDINE HYDROCHLORIDE
INJECTABLE; INJECTION
>A> RANITIDINE
>A> AP BEDFORD EQ 25MG BASE/ML N74764 001 Nov 19, 2004 Nov NEWA
ZANTAC
>D> + GLAXOSMITHKLINE EQ 25MG BASE/ML N19090 001 Oct 19, 1984 Nov CFTG
>A> AP + EQ 25MG BASE/ML N19090 001 Oct 19, 1984 Nov CFTG
SELEGILINE HYDROCHLORIDE
TABLET; ORAL
SELEGILINE HCL
>D> AB APOTEX 5MG N74871 001 Jun 06, 1997 Nov CRLD
>A> AB + 5MG N74871 001 Jun 06, 1997 Nov CRLD
SODIUM TETRADECYL SULFATE
INJECTABLE; INJECTION
SOTRADECOL
>A> BIONICHE PHARM USA 20MG/2ML (10MG/ML) N40541 001 Nov 12, 2004 Nov NEWA
>A> + 60MG/2ML (30MG/ML) N40541 002 Nov 12, 2004 Nov NEWA
>A> SOLIFENACIN SUCCINATE
>A> TABLET; ORAL
>A> VESICARE
>A> YAMANOUCHI 5MG N21518 001 Nov 19, 2004 Nov NEWA
>A> + 10MG N21518 002 Nov 19, 2004 Nov NEWA
SULFAMETHOXAZOLE; TRIMETHOPRIM
INJECTABLE; INJECTION
BACTRIM
>A> AP + MUTUAL PHARM 80MG/ML;16MG/ML N18374 001 Nov CAHN
>D> AP + WOMEN FIRST 80MG/ML;16MG/ML N18374 001 Nov CAHN
TABLET; ORAL
BACTRIM
>A> AB MUTUAL PHARM 400MG;80MG N17377 001 Nov CAHN
>D> AB WOMEN FIRST 400MG;80MG N17377 001 Nov CAHN
BACTRIM DS
>A> AB + MUTUAL PHARM 800MG;160MG N17377 002 Nov CAHN
>D> AB + WOMEN FIRST 800MG;160MG N17377 002 Nov CAHN
TECHNETIUM TC-99M SESTAMIBI KIT
INJECTABLE; INJECTION
MIRALUMA
>D> BRISTOL MYERS N/A N19785 003 May 23, 1997 Nov CRLD
>A> + N/A N19785 003 May 23, 1997 Nov CRLD
TERAZOSIN HYDROCHLORIDE
TABLET; ORAL
TERAZOSIN HCL
>D> AB TEVA EQ 1MG BASE N74446 001 May 18, 2000 Nov DISC
>A> @ EQ 1MG BASE N74446 001 May 18, 2000 Nov DISC
>D> AB EQ 2MG BASE N74446 002 May 18, 2000 Nov DISC
>A> @ EQ 2MG BASE N74446 002 May 18, 2000 Nov DISC
>D> AB EQ 5MG BASE N74446 003 May 18, 2000 Nov DISC
>A> @ EQ 5MG BASE N74446 003 May 18, 2000 Nov DISC
>D> AB EQ 10MG BASE N74446 004 May 18, 2000 Nov DISC
>A> @ EQ 10MG BASE N74446 004 May 18, 2000 Nov DISC
TIMOLOL MALEATE
SOLUTION/DROPS; OPHTHALMIC
TIMOLOL MALEATE
>D> AT AKORN EQ 0.25% BASE N74465 001 Mar 25, 1997 Nov DISC
>A> @ EQ 0.25% BASE N74465 001 Mar 25, 1997 Nov DISC
TREPROSTINIL SODIUM
>A> INJECTABLE; IV (INFUSION)
>A> REMODULIN
>A> UNITED THERAP 1MG/ML N21272 001 May 21, 2002 Nov CDFR
>A> 2.5MG/ML N21272 002 May 21, 2002 Nov CDFR
>A> 5MG/ML N21272 003 May 21, 2002 Nov CDFR
>A> + 10MG/ML N21272 004 May 21, 2002 Nov CDFR
>D> INJECTABLE; SUBCUTANEOUS
>D> REMODULIN
>D> UNITED THERAP 1MG/ML N21272 001 May 21, 2002 Nov CDFR
>D> 2.5MG/ML N21272 002 May 21, 2002 Nov CDFR
>D> 5MG/ML N21272 003 May 21, 2002 Nov CDFR
>D> + 10MG/ML N21272 004 May 21, 2002 Nov CDFR
TRIPTORELIN PAMOATE
INJECTABLE; INTRAMUSCULAR
TRELSTAR
>A> + WATSON LABS 11.25MG/VIAL N21288 001 Jun 29, 2001 Nov CAHN
>D> + WATSON PHARMS 11.25MG/VIAL N21288 001 Jun 29, 2001 Nov CAHN
TRELSTAR DEPOT
>A> + WATSON LABS EQ 3.75MG BASE/VIAL N20715 001 Jun 15, 2000 Nov CAHN
>D> + WATSON PHARMS EQ 3.75MG BASE/VIAL N20715 001 Jun 15, 2000 Nov CAHN
UROKINASE
INJECTABLE; INJECTION
ABBOKINASE
>A> + ABBOTT 250,000 IU/VIAL N21846 001 Nov CMS1
VANCOMYCIN HYDROCHLORIDE
CAPSULE; ORAL
VANCOCIN HCL
>D> LILLY EQ 125MG BASE N50606 001 Apr 15, 1986 Nov CAHN
>D> + EQ 250MG BASE N50606 002 Apr 15, 1986 Nov CAHN
>A> VIROPHARMA EQ 125MG BASE N50606 001 Apr 15, 1986 Nov CAHN
>A> + EQ 250MG BASE N50606 002 Apr 15, 1986 Nov CAHN
>D> ASPIRIN
>D> TABLET; ORAL
>D> BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN
>D> + BAYER 500MG N21317 001 Oct 18, 2001 Nov DISC
>A> @ 500MG N21317 001 Oct 18, 2001 Nov DISC
GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
MUCINEX D
>D> ADAMS 600MG;60MG N21585 001 Jun 22, 2004 Nov CAHN
>D> + 1.2GM;120MG N21585 002 Jun 22, 2004 Nov CAHN
>A> ADAMS LABS INC 600MG;60MG N21585 001 Jun 22, 2004 Nov CAHN
>A> + 1.2GM;120MG N21585 002 Jun 22, 2004 Nov CAHN
 Back
to Top 
Index Page
Date Created: November 17, 2004 |
|
